Who We Are

Global Health


Our Global Health division seeks innovative, ambitious, and scalable solutions to address health problems that have a major impact in developing countries. Learn more about the advisory committee.

Trevor Mundel


Trevor Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries.

Emilio Emini


Emilio A. Emini, Ph.D. leads the team focused on accelerating the reduction in the incidence of HIV infection, in high-burden geographies/populations of Southern and Eastern Africa.

William Foege

Senior Fellow

Dr. William Foege advises the foundation on strategies that could be usefully pursued in global health.

Dan Hartman


Dr. Dan Hartman, director, Integrated Development, leads a team that provides technical expertise in drug and diagnostic development.

Toni Hoover


Dr. Toni Hoover works on strategic planning and organizational development to advance the foundation’s principles.

Gilla Kaplan


Gilla Kaplan, director, Tuberculosis, leads the team that works to accelerate the reduction of TB incidence globally.

Chris Karp


Chris Karp leads the team that targets fundamental scientific and technological advances in global health to create and improve preventive and therapeutic interventions for infectious diseases.

Keith Klugman


Keith Klugman leads the foundation’s work to reduce deaths from pneumonia, neonatal sepsis, and meningitis in children.

Andrin Oswald


Dr. Andrin Oswald is the director of Life Sciences Partnerships, overseeing the foundation’s engagements with corporations.

Katey Einterz Owen


Dr. Katey Einterz Owen has end-to-end responsibility for the investment portfolio in controlling, eliminating, and eradicating the diseases of the London Declaration.

Mike Poole


Mike Poole is responsible for coordinating and evaluating new investment opportunities in R&D technologies, and oversees Global Health leadership engagements and strategic operations.

Dan Wattendorf


Dan Wattendorf leads efforts to identify and create biotechnology platforms that result in new options for global health.

Anita Zaidi


Anita Zaidi leads the work focused on vaccine development, surveillance and significantly reducing the adverse consequences of diarrheal and enteric infections.

Jennifer Weisman

Chief of Staff

Jennifer Weisman serves as an extension of the president, Global Health and drives the prioritization, communication, and execution of Global Health objectives.

Scientific Advisory Committee

Our Global Health Program advisory committee comprises a group of esteemed experts from outside of the foundation who offer a wide range of experiences and perspectives. This group plays an important role in strengthening our work by offering independent assessments of our strategies and helping us evaluate results.

Visit Our Blog